Mirae Asset Global Investments Co. Ltd. Has $268,000 Holdings in Tempus AI, Inc. (NASDAQ:TEM)

Mirae Asset Global Investments Co. Ltd. raised its position in Tempus AI, Inc. (NASDAQ:TEM) by 10.1% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 5,594 shares of the company’s stock after acquiring an additional 515 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Tempus AI were worth $268,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in TEM. Bartlett & CO. Wealth Management LLC boosted its position in shares of Tempus AI by 100.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company’s stock valued at $39,000 after buying an additional 400 shares during the last quarter. Spire Wealth Management purchased a new position in shares of Tempus AI during the first quarter valued at approximately $69,000. Harbour Capital Advisors LLC purchased a new position in shares of Tempus AI during the first quarter valued at approximately $450,000. Continuum Advisory LLC purchased a new position in shares of Tempus AI during the first quarter valued at approximately $39,000. Finally, Cambridge Investment Research Advisors Inc. purchased a new position in shares of Tempus AI during the first quarter valued at approximately $1,019,000. Institutional investors and hedge funds own 24.22% of the company’s stock.

Tempus AI Stock Performance

Shares of TEM opened at $60.65 on Monday. The firm has a market cap of $10.50 billion and a PE ratio of -7.78. The stock’s fifty day moving average price is $62.53 and its two-hundred day moving average price is $54.27. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.71 and a quick ratio of 1.56. Tempus AI, Inc. has a 1 year low of $30.81 and a 1 year high of $91.45.

Tempus AI (NASDAQ:TEM) last issued its earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $0.03. The firm had revenue of $255.74 million for the quarter, compared to analyst estimates of $248.13 million. Tempus AI had a negative return on equity of 533.21% and a negative net margin of 88.27%. The firm’s revenue was up 75.4% on a year-over-year basis. On average, equities research analysts forecast that Tempus AI, Inc. will post -6.15 EPS for the current year.

Insider Transactions at Tempus AI

In other Tempus AI news, EVP Erik Phelps sold 51,317 shares of the business’s stock in a transaction on Monday, June 16th. The stock was sold at an average price of $72.56, for a total value of $3,723,561.52. Following the sale, the executive vice president directly owned 97,779 shares in the company, valued at $7,094,844.24. The trade was a 34.42% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CAO Ryan M. Bartolucci sold 6,073 shares of the business’s stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $63.23, for a total value of $383,995.79. Following the completion of the sale, the chief accounting officer owned 47,799 shares in the company, valued at approximately $3,022,330.77. The trade was a 11.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 607,522 shares of company stock valued at $41,300,238. 27.60% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several research analysts recently issued reports on the company. Bank of America lifted their target price on Tempus AI from $68.00 to $70.00 and gave the company a “neutral” rating in a research report on Wednesday, June 25th. Guggenheim lifted their target price on Tempus AI from $65.00 to $75.00 and gave the company a “buy” rating in a research report on Monday, June 30th. Piper Sandler lifted their price target on Tempus AI from $55.00 to $70.00 and gave the stock a “neutral” rating in a report on Thursday, May 15th. BTIG Research began coverage on Tempus AI in a report on Monday, April 21st. They set a “buy” rating and a $60.00 price target on the stock. Finally, Needham & Company LLC reiterated a “buy” rating and set a $70.00 price target on shares of Tempus AI in a report on Wednesday, May 7th. Six equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, Tempus AI currently has an average rating of “Moderate Buy” and an average target price of $63.67.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.